Codexis (CDXS) EBT Margin Growth (1y) (2011 - 2026)
Codexis (CDXS) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 21,727.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,727.00 |
| Dec 31, 2025 | 7,305.00 |
| Sep 30, 2025 | -6,720.00 |
| Jun 30, 2025 | 19,854.00 |
| Mar 31, 2025 | -20,679.00 |
| Dec 31, 2024 | 9,480.00 |
| Sep 30, 2024 | 21,543.00 |
| Jun 30, 2024 | -5,478.00 |
| Mar 31, 2024 | 10,677.00 |
| Dec 31, 2023 | -8,025.00 |
| Sep 30, 2023 | -34,722.00 |
| Jun 30, 2023 | -22,369.00 |
| Mar 31, 2023 | -15,048.00 |
| Dec 31, 2022 | -2,158.00 |
| Sep 30, 2022 | -3,537.00 |
| Jun 30, 2022 | 1,013.00 |
| Mar 31, 2022 | 2,666.00 |
| Dec 31, 2021 | -2,271.00 |
| Sep 30, 2021 | 3,945.00 |
| Jun 30, 2021 | 2,361.00 |